IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY20 results · Jul–Sep 2019
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹448.96 crore (up 6.2% from Q2 FY19) and net profit of ₹87.70 crore (up 128.4% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a standalone basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 448.96 | 422.91 | +6.2% | 492.80 | −8.9% |
| Other income | 3.39 | 5.79 | −41.5% | 3.32 | +2.1% |
| Total income | 452.35 | 428.70 | +5.5% | 496.12 | −8.8% |
| Profit before tax | 121.38 | 58.83 | +106.3% | 131.02 | −7.4% |
| Net profit for the period | 87.70 | 38.40 | +128.4% | 85.32 | +2.8% |
| EPS, basic (₹) | 15.42 | 6.84 | +125.4% | 15.00 | +2.8% |
| Net margin (%) | 19.5 | 9.1 | 17.3 |
Standalone
- Filed with BSE
- 19 Nov 2019, 15:22 IST
- Board meeting
- 14 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Audited
- Source
- XBRL filing on BSE